HIF1A and inflammatory bowel disease: Since it seems that HIF-1α increases Treg cells production not only in inflammatory pathologies, such as rheumatoid arthritis or inflammatory bowel disease, but also in the tumor microenvironment, the development of an anticancer strategy targeting HIF-1 activity represents an interesting scientific topic.